Chronic nerve pain is a difficult condition that affects millions of people around the world. In the United States alone, more than 20 million people live with a type of nerve pain known as neuropathic pain.
This kind of pain happens when the nerves themselves are damaged or not working properly. Unlike pain from an injury, which usually heals over time, nerve pain can last for months or even years.
For some people, doctors can identify the cause of the nerve damage, such as diabetes, infections, or injuries. However, in many cases, the cause remains unclear. About one in four people with neuropathic pain fall into this group.
Their condition is known as cryptogenic sensory polyneuropathy, or CSPN. The word “cryptogenic” means that the cause is unknown, which makes the condition especially challenging for both patients and doctors.
When the cause of nerve pain is unknown, it becomes much harder to choose the right treatment. Doctors often need to try different medications to see what works. This process can take time, and some patients may not find enough relief. As a result, there is a strong need for better guidance on which treatments are most effective for this condition.
To address this problem, researchers from the University of Missouri carried out a large clinical study. Their goal was to compare several commonly used medications and see which ones worked best for people with CSPN. The results of the study were published in the journal JAMA Neurology and led by Dr. Richard Barohn and his research team.
The study included 402 adults who were experiencing significant nerve pain. All participants were at least 30 years old, and each person rated their pain at a level of 4 or higher on a scale from 0 to 10. This means that the participants were dealing with moderate to severe pain in their daily lives.
Each participant was randomly assigned to take one of four medications. These included nortriptyline, duloxetine, pregabalin, and mexiletine. Although all of these drugs are used to treat nerve pain, they work in different ways in the body.
Nortriptyline is an older type of antidepressant that has also been used for many years to treat nerve pain. Duloxetine is a newer antidepressant that affects certain chemicals in the brain that are linked to pain and mood.
Pregabalin is a medication often used to treat seizures, but it is also commonly prescribed for nerve pain. Mexiletine is usually used to treat heart rhythm problems, but it can sometimes help with nerve-related pain as well.
Participants took their assigned medication for 12 weeks. During this time, the researchers carefully monitored how much their pain improved. They also tracked whether participants continued taking the medication or stopped due to side effects or because it did not help.
By the end of the study, none of the medications worked for everyone, but some performed better than others. Nortriptyline showed the best overall results. About 25 percent of people taking this drug reported meaningful pain relief. It also had a relatively lower dropout rate, with 38 percent of participants stopping the medication.
Duloxetine also performed well. Around 23 percent of patients experienced improvement in their pain, and 37 percent stopped taking the drug during the study. This made duloxetine a close second in terms of both effectiveness and tolerance.
Pregabalin was less effective in this group, helping only about 15 percent of patients. Mexiletine had the highest dropout rate, with more than half of the participants choosing to stop the medication. This may have been due to side effects or a lack of noticeable benefit.
Although the results were not perfect, the study provides useful guidance. It suggests that nortriptyline and duloxetine may be the best first options for people with CSPN. These medications offered the best balance between reducing pain and being tolerable for patients.
The researchers also noted that other medications are commonly used to treat nerve pain, including gabapentin and venlafaxine. They recommend that future studies should include these drugs to provide a more complete understanding of treatment options.
This research is an important step forward for people living with unexplained nerve pain. By comparing treatments in a clear and structured way, the study helps doctors make more informed decisions. It may also reduce the time patients spend trying different medications without success.
In the future, more research may lead to even better treatments. For now, this study offers hope that people with CSPN can find relief more quickly and improve their quality of life.
If you care about pain, please read studies about how to manage your back pain, and Krill oil could improve muscle health in older people.
For more health information, please see recent studies about how to live pain-free with arthritis, and results showing common native American plant may help reduce diarrhea and pain.
Copyright © 2026 Knowridge Science Report. All rights reserved.
